HALOZYME THERAPEUTICS, INC. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Halozyme Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was 20.5 %, a 46.1% increase year-over-year.
  • Halozyme Therapeutics, Inc. annual Return On Assets for 2023 was 15.8 %, a 29.9% increase from 2022.
  • Halozyme Therapeutics, Inc. annual Return On Assets for 2022 was 12.2 %, a 67.7% decline from 2021.
  • Halozyme Therapeutics, Inc. annual Return On Assets for 2021 was 37.6 %, a 54.7% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 15.8 +3.63 +29.9% Jan 1, 2023 Dec 31, 2023
2022 12.2 -25.5 -67.7% Jan 1, 2022 Dec 31, 2022
2021 37.6 +13.3 +54.7% Jan 1, 2021 Dec 31, 2021
2020 24.3 +40.5 Jan 1, 2020 Dec 31, 2020
2019 -16.2 +1.12 +6.47% Jan 1, 2019 Dec 31, 2019
2018 -17.3 -34.7 -200% Jan 1, 2018 Dec 31, 2018
2017 17.4 +53.3 Jan 1, 2017 Dec 31, 2017
2016 -35.9 -16.7 -87.4% Jan 1, 2016 Dec 31, 2016
2015 -19.1 +19.4 +50.3% Jan 1, 2015 Dec 31, 2015
2014 -38.5 +38.1 +49.7% Jan 1, 2014 Dec 31, 2014
2013 -76.6 -33.6 -78.4% Jan 1, 2013 Dec 31, 2013
2012 -42.9 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.